Taken together, inhibition of DHCR24 by SH42 markedly increases liver desmosterol levels, accompanied by amelioration of diet‐induced hepatic steatosis without marked effects on body composition and glucose homeostasis. Here, DHCR24 is linked to fatty liver disease.